From Original Antigenic Sin to the Universal Influenza Virus Vaccine.

From Original Antigenic Sin to the Universal Influenza Virus Vaccine.
复制标题

DOI:
10.1016/j.it.2017.08.003
复制
发表时间:
2018-01
影响因子:
16.8
通讯作者:
Wilson PC
Wilson PC
中科院分区:
医学1区
文献类型:
--
作者:
Henry C;Palm AE;Krammer F;Wilson PC

文献摘要

参考文献

被引文献

相似文献

抗体反应对于预防流感病毒感染至关重要。人类一生中暴露在多种流感病毒中,免疫史显然会影响抗体反应的大小和质量。原抗原罪(OAS)概念是指首次遭遇流感病毒变异株对终身免疫的影响。尽管这一模型自发现以来一直受到挑战,但过去的暴露,很可能是一个人的第一次暴露,显然会影响后续反应中的目标表位。了解以前接触流感病毒如何形成对疫苗接种和感染的抗体反应是至关重要的,特别是在未来大流行的前景和有效开发通用流感疫苗的情况下。
Antibody responses are essential for protection against influenza virus infection. Humans are exposed to a multitude of influenza viruses throughout their lifetime and it is clear that immune history influences the magnitude and quality of the antibody response. The “original antigenic sin” (OAS) concept refers to the impact of the first influenza virus variant encounter on lifelong immunity. Although this model has been challenged since its discovery, past exposure, and likely one's first exposure, clearly affects the epitopes targeted in subsequent responses. Understanding how previous exposure to influenza virus shape antibody responses to vaccination and infection is critical, especially with the prospect of future pandemics and for the effective development of a universal influenza vaccine.
DOI: 10.1128/cvi.00396-10
发表时间: 2011-03-01
影响因子: --
作者:
Bodewes, R.;De Mutsert, G.;Rimmelzwaan, G. F.
通讯作者: Rimmelzwaan, G. F.
DOI: 10.3389/fimmu.2017.00238
发表时间: 2017
影响因子: 7.3
作者:
Bergström JJ;Xu H;Heyman B
通讯作者: Heyman B
DOI: 10.1126/scitranslmed.aad0522
发表时间: 2015-12-02
影响因子: 17.1
作者:
Andrews SF;Huang Y;Kaur K;Popova LI;Ho IY;Pauli NT;Henry Dunand CJ;Taylor WM;Lim S;Huang M;Qu X;Lee JH;Salgado-Ferrer M;Krammer F;Palese P;Wrammert J;Ahmed R;Wilson PC
通讯作者: Wilson PC
DOI: 10.1016/j.vaccine.2004.08.053
发表时间: 2005-02-03
期刊: VACCINE
影响因子: 5.5
作者:
Gulati, U;Kumari, K;Air, GM
通讯作者: Air, GM
DOI: 10.1073/pnas.1319058110
发表时间: 2014-01-07
影响因子: 11.1
作者:
Friesen, Robert H. E.;Lee, Peter S.;Wilson, Ian A.
通讯作者: Wilson, Ian A.